Sheryl A. Zelenitsky
University of Manitoba
Winnipeg
Canada
Name/email consistency: high
- Pharmacodynamics of empirical antibiotic monotherapies for an intensive care unit (ICU) population based on Canadian surveillance data. Zelenitsky, S.A., Ariano, R.E., Zhanel, G.G. J. Antimicrob. Chemother. (2011)
- Support for higher ciprofloxacin AUC 24/MIC targets in treating Enterobacteriaceae bloodstream infection. Zelenitsky, S.A., Ariano, R.E. J. Antimicrob. Chemother. (2010)
- Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia. Zelenitsky, S.A., Iacovides, H., Ariano, R.E., Harding, G.K. Diagn. Microbiol. Infect. Dis. (2005)
- Evaluating ciprofloxacin dosing for Pseudomonas aeruginosa infection by using clinical outcome-based Monte Carlo simulations. Zelenitsky, S., Ariano, R., Harding, G., Forrest, A. Antimicrob. Agents Chemother. (2005)
- AUC(0-t)/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in vitro infection model. Zelenitsky, S.A., Ariano, R.E., Iacovides, H., Sun, S., Harding, G.K. J. Antimicrob. Chemother. (2003)
- Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis. Zelenitsky, S.A., Harding, G.K., Sun, S., Ubhi, K., Ariano, R.E. J. Antimicrob. Chemother. (2003)
- Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy. Zelenitsky, S.A., Ariano, R.E., Harding, G.K., Silverman, R.E. Antimicrob. Agents Chemother. (2002)
- A prospective, randomized, double-blind studyof single high dose versus multiple standard dose gentamicin both in combination withmetronidazole for colorectal surgicalprophylaxis. Zelenitsky, S.A., Silverman, R.E., Duckworth, H., Harding, G.K. J. Hosp. Infect. (2000)
- Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Zelenitsky, S., Barns, L., Findlay, I., Alfa, M., Ariano, R., Fine, A., Harding, G. Am. J. Kidney Dis. (2000)
- Synergy of an investigational glycopeptide, LY333328, with once-daily gentamicin against vancomycin-resistant Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic model. Zelenitsky, S.A., Booker, B., Laing, N., Karlowsky, J.A., Hoban, D.J., Zhanel, G.G. Antimicrob. Agents Chemother. (1999)